We are live on ! Find out more
PAVM icon

PAVmed
PAVM

7 hedge funds and large institutions have $512K invested in PAVmed in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.39% less ownership

Funds ownership: 2.41% → 2.02% (-0.39%)

50% less funds holding

Funds holding: 14 → 7 (-7)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

71% less capital inflows, than outflows

Capital inflows: $53.4K | Capital outflows: $187K

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
7
Holders Change
-7
Holders Change %
-50%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$25.5K
2
Two Sigma Securities
Two Sigma Securities
New York
+$19.6K
3
Glassman Wealth Services
Glassman Wealth Services
Virginia
+$8.32K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$40K
2
Renaissance Technologies
Renaissance Technologies
New York
-$37.7K
3
Millennium Management
Millennium Management
New York
-$32K
4
Moloney Securities Asset Management
Moloney Securities Asset Management
Missouri
-$21.1K
5
Virtu Financial
Virtu Financial
New York
-$17K

PAVM Hedge Fund Activity: Q4 2018 in Review

7 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2018, worth a combined $512K — down 38% from $829K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of PAVM and 2 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $25.5K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $40K sold.

  • 7 institutional investors held PAVmed (PAVM) as of Q4 2018, down from 14 in Q3 2018.
  • Funds reported $512K of PAVmed stock for Q4 2018, down 38% quarter-over-quarter.
  • 2 funds opened new PAVmed positions in Q4 2018 and 9 closed out, a net change of -7 holders.
  • The largest PAVmed buyer in Q4 2018 was Vanguard Group, an estimated $25.5K added.
  • The largest PAVmed seller in Q4 2018 was Susquehanna International Group, an estimated $40K sold.

Based on aggregated 13F filings for Q4 2018.